Finally, excessive recruitment and deposition of HSCs at injury sites is a key driver of liver cirrhosis suggesting that SAA1/TLR2 axis may provide a novel target to anti-fibrosis drug development. This evidence concerns the gene TLR2 and cirrhosis of liver.